Bioventus (BVS) Operating Margin (2020 - 2026)

Bioventus (BVS) has 7 years of Operating Margin data on file, last reported at 6.37% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin rose 244.0% year-over-year to 6.37%; the trailing twelve-month figure through Mar 2026 stood at 9.98% (up 1267.0% YoY), and the FY2025 full-year result was 9.5%, up 1215.0% from the prior year.
• Operating Margin for Q1 2026 stood at 6.37%, down from 12.34% in the prior quarter.
• Across five years, Operating Margin topped out at 12.44% in Q2 2025 and bottomed at 98.58% in Q4 2022.
• The 5-year median for Operating Margin is 2.62% (2024), against an average of 9.84%.
• The widest annual swing landed in 2022, when Operating Margin plunged 9762 bps; it then soared 10058 bps in 2023.
• A 5-year view of Operating Margin shows it stood at 12.43% in 2022, then jumped by 107 bps to 0.86% in 2023, then jumped by 483 bps to 5.01% in 2024, then surged by 146 bps to 12.34% in 2025, then tumbled by 48 bps to 6.37% in 2026.
• The last three Operating Margin figures came in at 6.37% (Q1 2026), 12.34% (Q4 2025), and 8.12% (Q3 2025), per Business Quant data.

Peer Comparison